Protagonist Therapeutics, Inc (PTGX) › Operating IncomeProtagonist Therapeutics, Inc (PTGX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$9.32M2015: -$14.79M2016: -$32.67M2017: -$37.90M2018: -$42.27M2019: -$80.52M2020: -$64.52M2021: -$125.84M2022: -$131.37M2023: -$93.65M2024: $252.84M2025: -$158.13M-$158.13M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$158.13M-162.5%2024$252.84M+370.0%2023-$93.65M+28.7%2022-$131.37M-4.4%2021-$125.84M-95.1%2020-$64.52M+19.9%2019-$80.52M-90.5%2018-$42.27M-11.5%2017-$37.90M-16.0%2016-$32.67M-120.8%2015-$14.79M-58.8%2014-$9.32M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share